The best antibiotic for a UTI in an elderly person depends on kidney function, other medications, and whether the infection is in the bladder or has spread deeper. For uncomplicated lower UTIs, nitrofurantoin and trimethoprim are the most commonly recommended first-line options, with fosfomycin as an alternative. But choosing the right one for an older adult involves more consideration than it would for a younger person, because kidney decline, drug interactions, and the high rate of bacteria in urine without actual infection all complicate the picture.
First-Line Antibiotics for Uncomplicated UTIs
For a straightforward bladder infection in an older woman, guidelines generally point to three antibiotics. Trimethoprim (sometimes combined with sulfamethoxazole) has long been a standard first choice, typically prescribed for three days in women. Nitrofurantoin is an equally strong option and is increasingly preferred in Europe as a first-line agent. Fosfomycin, given as a single dose, rounds out the short list. All three work well against the bacteria that cause most UTIs, but each carries specific trade-offs for older adults that your prescriber needs to weigh.
One important limitation: both nitrofurantoin and fosfomycin only reach effective concentrations in the bladder and lower urinary tract. They should not be used when an infection has spread to the kidneys or bloodstream, which typically shows up as fever, flank pain, or feeling systemically unwell. In those cases, a broader-spectrum antibiotic is necessary.
Why Kidney Function Changes the Choice
Aging kidneys filter blood more slowly, and this directly affects which antibiotics are safe. Nitrofurantoin is the clearest example. It works by concentrating in urine, so when the kidneys aren’t filtering efficiently, the drug can’t reach high enough levels in the bladder to kill bacteria. Worse, it can build up in the blood and become toxic. Current guidelines say nitrofurantoin should be avoided when kidney filtration (creatinine clearance) drops below 30 mL/min. An older version of the guidelines used a more conservative cutoff of 60 mL/min, but that was revised in 2015 after studies showed the drug was still safe and effective between 30 and 60.
Trimethoprim-sulfamethoxazole also requires dose adjustments when kidney function falls below 30 mL/min. Fosfomycin may be the simplest option in people with reduced kidney function, since it’s given as a single dose and doesn’t carry the same renal restrictions, though availability varies by country.
Drug Interactions That Matter in Older Adults
Many older adults take blood pressure medications like ACE inhibitors or ARBs. Combining these with trimethoprim-sulfamethoxazole creates a real risk: a dangerous spike in blood potassium levels. A large population-based study found that older patients on ACE inhibitors or ARBs who took trimethoprim-sulfamethoxazole had nearly seven times the risk of being hospitalized for high potassium compared to those given a different antibiotic. This is not a rare or theoretical concern. If you or a family member takes blood pressure medication in these classes, the prescriber needs to know before choosing this antibiotic.
Blood thinners are another common issue. Both trimethoprim-sulfamethoxazole and ciprofloxacin can amplify the effect of warfarin, increasing bleeding risk. Seizure medications like phenytoin also interact badly with trimethoprim-sulfamethoxazole. The more medications someone takes, the more carefully the antibiotic choice needs to be made.
Why Fluoroquinolones Are a Last Resort
Ciprofloxacin and levofloxacin belong to a class called fluoroquinolones. They’re powerful, broad-spectrum antibiotics that were once widely prescribed for UTIs. For older adults, they now carry an FDA black box warning, the strongest safety alert possible, for the risk of tendon rupture and tendinitis. The risk is highest in people over 60, those taking corticosteroids, and organ transplant recipients.
Achilles tendon rupture is the most common injury, but fluoroquinolones can also cause confusion, hallucinations, depression, heart rhythm problems, and severe diarrhea from C. difficile infection. For a simple bladder infection, the risks almost never justify the benefit. These drugs are reserved for complicated or resistant infections where safer options won’t work.
Bacteria in Urine Doesn’t Always Mean Infection
This is one of the most important and most misunderstood aspects of UTIs in older adults. Many elderly people, especially those in nursing homes or with catheters, have bacteria growing in their urine without having an actual infection. This is called asymptomatic bacteriuria, and it is extremely common. Treating it with antibiotics does not help and can cause harm, including drug side effects and antibiotic resistance.
The Infectious Diseases Society of America recommends against treating asymptomatic bacteriuria in older adults. The key distinction is the presence of urinary symptoms: pain or burning during urination, urgency, frequency, or blood in the urine. In older patients with cognitive or functional impairment who can’t clearly report symptoms, the guideline recommends looking for other explanations and observing carefully rather than automatically starting antibiotics, unless there are signs of systemic infection like fever or a drop in blood pressure.
UTIs in the elderly can present atypically, with confusion, new incontinence, falls, drowsiness, or poor appetite rather than classic burning and urgency. But confusion alone, combined with bacteria in the urine, is not enough to diagnose a UTI. Delirium has many causes, and jumping to antibiotics based on a positive urine culture in someone without clear urinary symptoms leads to significant overtreatment.
How Long Treatment Should Last
Older women with uncomplicated bladder infections were traditionally given longer courses of antibiotics than younger women, sometimes seven to 14 days. A Cochrane review found no strong evidence to support this practice and noted that it increases the risk of side effects. A three-to-six-day course appears to be sufficient for most uncomplicated lower UTIs in elderly women.
Men are treated differently. Because UTIs in men are frequently associated with prostate enlargement or other structural factors, they’re almost always classified as complicated infections. Courses of seven days or more are standard for men, and the initial antibiotic choice is often broader-spectrum until culture results come back showing which specific drug will work.
Preventing Recurrent UTIs Without Antibiotics
Recurrent UTIs are common in older adults, and long-term low-dose antibiotics have traditionally been used to prevent them. This approach carries real downsides, including resistance and side effects. Nitrofurantoin, for example, is specifically flagged in geriatric safety guidelines as inappropriate for long-term suppressive use.
Methenamine hippurate is a non-antibiotic alternative that works by making urine acidic enough to inhibit bacterial growth. A study in older adults found that the average time between UTIs increased from 3.3 months before starting methenamine to 5.5 months afterward. About one in five patients in the study had no UTI at all after starting it. Notably, it worked across varying degrees of kidney function, and because it doesn’t act like a traditional antibiotic, bacteria don’t develop resistance to it. For older adults caught in a cycle of repeated infections and repeated antibiotic courses, it’s worth discussing as a preventive strategy.